https://doi.org/10.1186/s12885-020-07251-z
H
Haiping Jiang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
86
Papers
1.7K
Citations
19
h-index
30
i10-index
Haiping Jiang is an academic researcher from California Institute for Regenerative Medicine. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Lung Cancer Treatments and Mutations & Gastrointestinal Tumor Research and Treatment. The author has an h-index of 19, co-authored 74 publications.
Papers by this author
worksSafety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial
2020 · BMC Cancer · 62 citations
RRM2 Mediates the Anti-Tumor Effect of the Natural Product Pectolinarigenin on Glioblastoma Through Promoting CDK1 Protein Degradation by Increasing Autophagic Flux
2022 · Frontiers in Oncology · 21 citations
https://doi.org/10.3389/fonc.2022.887294
Functional mouse hepatocytes derived from interspecies chimeric livers effectively mitigate chronic liver fibrosis
2024 · Stem Cell Reports · 5 citations
https://doi.org/10.1016/j.stemcr.2024.04.006
A retrospective study of adjuvant albumin-bound paclitaxel plus S-1 after D2 gastrectomy versus oxaliplatin plus S-1 in gastric cancer
2024 · Scientific Reports · 2 citations
https://doi.org/10.1038/s41598-024-65724-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat